BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260605
DTSTAMP:20260609T133930
CREATED:20260415T152522Z
LAST-MODIFIED:20260415T152610Z
UID:10200-1780358400-1780617599@thebiocalendar.com
SUMMARY:Global Healthcare Conference in New York
DESCRIPTION:By invitation only.  You must be pre-registered by your Jefferies representative in order to attend. \nThe Jefferies Global Healthcare Conference in New York will take place on Tuesday\, June 2 – Thursday June 4\, 2026. This year’s conference will focus on life sciences companies in the biotechnology\, life sciences tools and services\, medical technology\, and pharmaceutical sectors. \nWe will dedicate Tuesday\, June 2 to private companies only. The format will consist of 1x1s and small group meetings between select private companies and investors. There will be no presentations.  On Wednesday\, June 3 & Thursday\, June 4\, we will host over 300 public companies for two full days of presentations\, fireside chats\, 1x1s and small group meetings. \nWe look forward to organizing another exciting conference\, as we bring together over 3\,000 leading executives\, institutional investors\, private equity investors & VCs to address near- and long-term investment opportunities and discuss the current trends driving healthcare in the U.S. and internationally.
URL:https://thebiocalendar.com/event/global-healthcare-conference-in-new-york/
LOCATION:New York\, New York\, NY\, United States
CATEGORIES:Investor
ATTACH;FMTTYPE=image/webp:https://thebiocalendar.com/wp-content/uploads/2026/04/Global-HC-Conf-New-York-2026-Web-Tile-1200x490px-300dpi.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260604
DTSTAMP:20260609T133930
CREATED:20260504T221327Z
LAST-MODIFIED:20260504T221327Z
UID:10333-1780358400-1780531199@thebiocalendar.com
SUMMARY:Future BioTech Expo
DESCRIPTION:Future BioTech Expo is a purpose built international exhibition and conference dedicated to red biotechnology and the science transforming how we prevent\, diagnose\, and treat disease.\nHeld at the Hilton Houston North on June 2–3\, 2026\, #FBE26 unites pharma innovators\, clinical researchers\, biotech CEOs\, investors\, and policymakers under one roof in one of America’s fastest growing life sciences cities. This isn’t just any other industry event. It’s a focused\, high signal environment built for deals\, discovery\, and long term partnerships.
URL:https://thebiocalendar.com/event/future-biotech-expo/
LOCATION:Houston\, Houston\, TX\, 77001\, United States
CATEGORIES:Expo
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260603
DTEND;VALUE=DATE:20260606
DTSTAMP:20260609T133930
CREATED:20260504T220856Z
LAST-MODIFIED:20260504T220856Z
UID:10329-1780444800-1780703999@thebiocalendar.com
SUMMARY:BioCentury Grand Rounds - U.S.
DESCRIPTION:Connecting Translational Science with the Right Partners to Advance Drug Development\nJoin VCs\, biopharma decision-makers and academic innovators in Seattle\, June 2026\, for the 3rd BioCentury Grand Rounds – U.S. \nThis R&D conference brings together leaders at the forefront of translational science to explore the breakthroughs\, bottlenecks and strategies shaping the future of drug development. \nUnlock transformative opportunities debate scientific hurdles with the innovators driving biopharma advancements \nDiscover cutting-edge science with commercial potential \nGain industry insights through presentations by emerging biotechs and academic innovators \nSchedule partnering meetings with VCs\, pharmas and leading academics
URL:https://thebiocalendar.com/event/biocentury-grand-rounds-u-s/
LOCATION:Seattle\, Seattle\, WA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260603
DTEND;VALUE=DATE:20260605
DTSTAMP:20260609T133930
CREATED:20260504T221221Z
LAST-MODIFIED:20260504T221221Z
UID:10332-1780444800-1780617599@thebiocalendar.com
SUMMARY:The Festival of Genomics\, Biodata & AI
DESCRIPTION:From data to decisions. From discovery to better patient outcomes. \n\n\nThe Festival of Genomics\, Biodata & AI returns to Boston at a critical moment for the US life sciences community. Funding pressures\, rising development costs and intensifying competition are colliding with an unprecedented opportunity: the convergence of multi-omics\, large-scale biodata and artificial intelligence. \nTo stay ahead\, organizations must do more than generate data – they must integrate technologies\, break down silos and translate insight into measurable progress\, in research\, drug discovery and translation into the clinic.
URL:https://thebiocalendar.com/event/the-festival-of-genomics-biodata-ai/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Forum,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260603T083000
DTEND;TZID=America/Los_Angeles:20260603T150000
DTSTAMP:20260609T133930
CREATED:20260419T120546Z
LAST-MODIFIED:20260419T120546Z
UID:10231-1780475400-1780498800@thebiocalendar.com
SUMMARY:Better Together: A Pharma & Biotech EHS Forum
DESCRIPTION:Reimagine what’s possible—together.\nJoin BSI Consulting for an expert-led forum designed for pharma and biotech professionals who are shaping the next era of EHS. Connect with peers\, challenge assumptions\, and explore practical solutions to the industry’s most pressing risks and opportunities. \nThis event brings together leaders at the forefront of life sciences in EHS to learn\, debate\, and reimagine what’s possible. \nFeaturing speakers from:  \nAstraZeneca · Intellia Therapeutics · Leading multinational biotech organizations · BSI Consulting \nWhat you’ll experience\nDuring this one-day event\, you’ll be part of conversations that matter. \nKeynote spotlight: AI Large and Small  \nHear from an AI practitioner on the types of automation systems to support problem-solving\, and the opportunities and limitations of AI use. \nMulti-track roundtables with leading organizations  \nJoin guest speakers and BSI Consulting as they explore: \n\nBridging competency gaps across EHS teams.\nUnseen risks of waste misclassification in labs and R&D environments.\nAI governance\, compliance\, and date integrity in life sciences.\nBuilding biosafety systems that move beyond minimum compliance.\nSupply chain risk – details to be announced soon! \n\nInteractive discussions \nCollaborate in facilitated groups to identify shared industry challenges and co-create actionable solutions. \nYou’ll walk away with new relationships\, practical insights\, and a renewed sense of purpose in your work. \nView the full agenda!
URL:https://thebiocalendar.com/event/better-together-a-pharma-biotech-ehs-forum/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260603T100000
DTEND;TZID=America/New_York:20260603T110000
DTSTAMP:20260609T133930
CREATED:20260428T174731Z
LAST-MODIFIED:20260529T171519Z
UID:10272-1780480800-1780484400@thebiocalendar.com
SUMMARY:2026 Manufacturing Trends Reshaping Life Sciences: AI\, Integration\, and Workforce Readiness
DESCRIPTION:The webinar also highlights the growing role of AI within regulated manufacturing environments. Rather than treating AI as an add-on\, the session outlines how to embed it into validated frameworks to support predictive maintenance\, yield optimization\, and faster product release cycles.
URL:https://thebiocalendar.com/event/2026-manufacturing-trends-reshaping-life-sciences-ai-integration-and-workforce-readiness-2/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/06-03-26-MasterControl-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260603T110000
DTEND;TZID=America/New_York:20260603T120000
DTSTAMP:20260609T133930
CREATED:20260428T162322Z
LAST-MODIFIED:20260526T212820Z
UID:10268-1780484400-1780488000@thebiocalendar.com
SUMMARY:Hidden in Plain Sight: How Solid-State Science Solves Your Toughest API Challenges
DESCRIPTION:This webinar series explores two powerful\, complementary disciplines that CDMOs leverage to tackle these challenges head-on. First\, we examine the solid-state domain\, exploring how targeted crystallization development can directly address purification\, filtration\, stability\, and processability challenges from lab scale through commercialization. Then\, we see how chromatographic modeling tools in combination with innovative techniques like “fraction mapping\,” can improve efficiency\, recovery\, and purity across various scales
URL:https://thebiocalendar.com/event/hidden-in-plain-sight-how-solid-state-science-solves-your-toughest-api-challenges/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/06-03-26-MilliporeSigma-Reg-1920x250-PART-ONE.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260603T110000
DTEND;TZID=America/Los_Angeles:20260603T120000
DTSTAMP:20260609T133930
CREATED:20260512T141741Z
LAST-MODIFIED:20260522T082729Z
UID:10432-1780484400-1780488000@thebiocalendar.com
SUMMARY:Faster Clones\, Simpler Process: What’s Changing in CHO Expression?
DESCRIPTION:CHO expression continues to evolve\, and recent advances are reshaping how quickly and efficiently high-performing cell lines are developed. In this webinar\, experts explore the latest innovations in the GS® Expression System\, highlighting how advanced vector design\, stronger selection stringency\, and enhanced promoter control are driving higher titers\, more stable pools\, and faster timelines from DNA to lead clone. \nKey Learning Objectives:\n– Understand the critical design elements of CHO expression vectors\n– Explore the development and performance advantages of improved glutamine synthetase selection stringency\n– Discover emerging data driven strategies for improving gene expression control in CHO cells
URL:https://thebiocalendar.com/event/faster-clones-simpler-process-whats-changing-in-cho-expression-2/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-03-26-Lonza-eblast-700x200-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260604
DTEND;VALUE=DATE:20260606
DTSTAMP:20260609T133930
CREATED:20260501T115308Z
LAST-MODIFIED:20260501T115308Z
UID:10322-1780531200-1780703999@thebiocalendar.com
SUMMARY:NYC AI x Longevity Summit
DESCRIPTION:Dive into the future of aging with cutting-edge AI breakthroughs at this can’t-miss summit! \n\n\n\n\nJune 4–5\, 2026 | BioLabs@NYU Langone\, Long Island City\, Queens \nLongevity science is at an inflection point. Foundation models are learning the language of biology\, aging clocks are quantifying human health with new precision\, and a generation of therapeutics and clinical platforms is emerging to act on those signals. \nThe inaugural theme of the Summit\, Signal to Intervention\, explores how AI is compressing the distance between discovery and real-world impact. \nAs a flagship event of Longevity Global NYC\, the AI x Longevity Summit convenes the researchers\, clinicians\, founders\, and engineers building the next generation of longevity infrastructure. Hosted at BioLabs@NYU Langone in the heart of the city’s biotech corridor\, the Summit is where technical depth meets translational ambition.
URL:https://thebiocalendar.com/event/nyc-ai-x-longevity-summit/
LOCATION:New York\, New York\, NY\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260604
DTEND;VALUE=DATE:20260606
DTSTAMP:20260609T133930
CREATED:20260527T225156Z
LAST-MODIFIED:20260527T225156Z
UID:10521-1780531200-1780703999@thebiocalendar.com
SUMMARY:Medical Device & Digital Health Conference
DESCRIPTION:Join us for our 33rd Annual MDC\, which features engaging panel sessions and keynote addresses\, a Partnering Hall connecting attendees with start-ups and investors from around the globe\, the MedTech Innovator pitch event\, and a lively wine tasting reception where venture capitalists serve as sommeliers.
URL:https://thebiocalendar.com/event/medical-device-digital-health-conference/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260604T080000
DTEND;TZID=America/Los_Angeles:20260604T160000
DTSTAMP:20260609T133930
CREATED:20260521T154458Z
LAST-MODIFIED:20260521T154519Z
UID:10503-1780560000-1780588800@thebiocalendar.com
SUMMARY:2026 Life Sciences Workforce Conference
DESCRIPTION:MassBioEd’s Annual Life Science Workforce Conference brings together representatives from the life sciences industry\, academic institutions\, training providers\, government and community to explore key issues and strategies in building a strong life science workforce in Massachusetts. \nThe 2026 Life Sciences Workforce Conference: Building Talent Pathways in a Dynamic Time: Massachusetts Prepares the Future Workforce will be held on \nJune 4th at Boston University
URL:https://thebiocalendar.com/event/2026-life-sciences-workforce-conference/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Networking,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260604T110000
DTEND;TZID=America/Los_Angeles:20260604T120000
DTSTAMP:20260609T133930
CREATED:20260417T125838Z
LAST-MODIFIED:20260522T082702Z
UID:10226-1780570800-1780574400@thebiocalendar.com
SUMMARY:Supporting Efficient mAb Development with a Flexible Downstream Purification Toolkit
DESCRIPTION:Bringing innovative antibody therapeutics to market quickly requires more than upstream efficiency. It demands adaptable and robust downstream purification strategies. \nAs novel mAb formats increase in complexity\, purification challenges grow. Achieving required purity and yield often extends beyond traditional 2–3 step platform processes\, requiring expanded chromatography options and optimized buffer systems. \nIn this webinar\, we will discuss: \n– Practical strategies for designing a flexible downstream purification toolkit\n– Approaches to buffer optimization for challenging antibody molecules\n– Ways to streamline process development while maintaining performance \nRegister to learn how a well-designed purification toolkit can help accelerate development timelines and improve process robustness.
URL:https://thebiocalendar.com/event/supporting-efficient-mab-development-with-a-flexible-downstream-purification-toolkit/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/06-04-26-Thermo-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260604T110000
DTEND;TZID=America/Los_Angeles:20260604T120000
DTSTAMP:20260609T133930
CREATED:20260506T133246Z
LAST-MODIFIED:20260522T082619Z
UID:10374-1780570800-1780574400@thebiocalendar.com
SUMMARY:Helping ensure safer immunotherapies: From gene editing to next-generation sequencing (NGS)-based T cell characterization
DESCRIPTION:Immune checkpoint inhibitors have transformed cancer treatment\, but response rates remain limited\, and immune-related toxicities continue to pose challenges. Gene editing of therapeutic T cells offers a promising path to help enhance specificity and safety by directly modulating checkpoint expression. \nIn this webinar\, we explore how gene-edited T cells targeting PD-1 and TIGIT can improve anti-tumor activity\, based on preclinical models and ongoing translational research. We will present how tumor-infiltrating lymphocytes (TILs) derived from melanoma metastases are engineered\, expanded and functionally characterized to assess their therapeutic potential. \nBeyond the biology\, this session highlights the critical role of integrated genomic workflows in enabling these insights. From high-quality nucleic acid extraction to next-generation sequencing (NGS)-based transcriptomic profiling\, we highlight how automated\, high-throughput sample preparation and NGS downstream analysis enable reliable identification of gene expression changes driving T cell function and efficacy. \nJoin us to learn how combining advanced cell engineering with end-to-end genomic solutions can accelerate cell therapy discovery and lead selection\, bridging the gap between experimental design and actionable insight. \nLearning objectives:\n~ Understand how gene editing of immune checkpoints (PD-1\, TIGIT) can enhance T cell–based cancer therapies\n~ Learn how integrated workflows\, from automated\, high-throughput nucleic acid extraction to NGS\, enable high-quality\, reproducible transcriptomic insights\n~ Discover how genomic data can inform functional characterization and support cell therapy\, lead discovery and development
URL:https://thebiocalendar.com/event/helping-ensure-safer-immunotherapies-from-gene-editing-to-next-generation-sequencing-ngs-based-t-cell-characterization/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-04-26-Qiagen-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260604T110000
DTEND;TZID=America/Los_Angeles:20260604T120000
DTSTAMP:20260609T133930
CREATED:20260512T142112Z
LAST-MODIFIED:20260522T082550Z
UID:10436-1780570800-1780574400@thebiocalendar.com
SUMMARY:Beyond Data Packages: Derisking Tech Transfer To CDMOs
DESCRIPTION:Technology transfer to a CDMO is rarely as simple as handing over a data package. From documentation gaps and equipment differences to method variability and global standards\, many programs encounter avoidable risks that can derail timelines and increase cost. In this Outsourced Pharma Live session\, industry experts share practical strategies to help sponsors better prepare for tech transfer and align more effectively with CDMO partners. \nJoin us to learn how tools like smarter documentation systems\, design of experiments\, and in silico modeling can support stronger CMC alignment and improve the likelihood of a right-first-time transfer—across small molecules\, biologics\, and advanced therapies.
URL:https://thebiocalendar.com/event/beyond-data-packages-derisking-tech-transfer-to-cdmos/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/26_06-OPL-HTML-600x300-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260604T160000
DTEND;TZID=America/New_York:20260604T183000
DTSTAMP:20260609T133930
CREATED:20260430T154259Z
LAST-MODIFIED:20260522T082523Z
UID:10312-1780588800-1780597800@thebiocalendar.com
SUMMARY:BVS' Summer Biotech Community Celebration at Tech Square\, Cambridge
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event at Tech Square. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nAll the biotech tenants at 100-700 Technology Square and other companies in the Cambridge vicinity are invited to attend this event. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nDelicious Food & Drinks: Enjoy delicious refreshments as you network and explore the vendor exhibits. \nAdmission Details: \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions\,etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-summer-biotech-community-celebration-at-tech-square-cambridge-3/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Expo,Networking
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/04/BVS-Biotech-Event-Flyer-06-04-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260606
DTEND;VALUE=DATE:20260611
DTSTAMP:20260609T133930
CREATED:20260504T221047Z
LAST-MODIFIED:20260504T221047Z
UID:10330-1780704000-1781135999@thebiocalendar.com
SUMMARY:CYTO 2026
DESCRIPTION:CYTO 2026\, the 39th annual Congress of the International Society for the Advancement of Cytometry\, is the premier\, inclusive\, and international conference on the many facets of cytometry science and engineering. Guided by this year’s theme\, Cytometry: The Next Wave\, the meeting will showcase groundbreaking innovations and emerging directions shaping the field. Join us in West Palm Beach\, Florida—a destination celebrated for its year-round sunshine\, beautiful beaches\, vibrant arts scene\, and welcoming community. Home to a growing life sciences ecosystem\, anchored by leading biomedical research institutes\, innovative biotech companies\, and renowned medical centers\, this unique blend of community spirit and scientific innovation makes West Palm Beach the ideal setting for charting the next wave of cytometry at CYTO 2026.
URL:https://thebiocalendar.com/event/cyto-2026/
LOCATION:West Palm Beach\, West Palm Beach\, FL\, United States
CATEGORIES:Academic Research,Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260609T110000
DTEND;TZID=America/Los_Angeles:20260609T120000
DTSTAMP:20260609T133930
CREATED:20260519T185932Z
LAST-MODIFIED:20260522T082449Z
UID:10469-1781002800-1781006400@thebiocalendar.com
SUMMARY:Cracking Complexity: Learnings from 70+ Bispecific Antibody Programs
DESCRIPTION:In this webinar\, Lonza experts share insights from 70+ bispecific programs\, revealing the most common early‑stage risks across analytical development\, downstream purification\, and drug product formulation. You’ll learn where challenges typically emerge before IND\, how early decisions shape CMC readiness\, and when to rely on platform approaches versus molecule‑specific strategies to avoid costly delays. \nKey Learning Objectives:\n– Identify where development risks matter most before IND and what early stage challenges bispecific antibody programs most commonly run into\n– Understand how early analytical\, downstream\, and drug product formulation decisions can either accelerate progress or create downstream CMC and IND readiness challenges\n– Learn how Lonza balances speed and risk by knowing when platform approaches are sufficient and when molecule specific strategies are needed to avoid costly surprises
URL:https://thebiocalendar.com/event/cracking-complexity-learnings-from-70-bispecific-antibody-programs/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-09-26-Lonza-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T110000
DTEND;TZID=America/Los_Angeles:20260610T120000
DTSTAMP:20260609T133930
CREATED:20260519T191159Z
LAST-MODIFIED:20260522T082428Z
UID:10477-1781089200-1781092800@thebiocalendar.com
SUMMARY:Viral Safety Testing in Biologics: Detecting What Current Methods Miss
DESCRIPTION:This webinar breaks down how evolving expectations under ICH Q5A(R2) are reshaping viral detection strategies\, shifting the industry from targeted testing toward broader\, more sensitive approaches. Through real‑world examples\, you’ll learn where current methods fall short\, how newer technologies expand visibility\, and how teams can strengthen viral safety programs without disrupting development timelines or regulatory alignment. \nWatch the discussion to learn how to modernize viral safety testing and uncover what traditional methods may be missing.
URL:https://thebiocalendar.com/event/viral-safety-testing-in-biologics-detecting-what-current-methods-miss/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-10-26-Minaris-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260611T110000
DTEND;TZID=America/Los_Angeles:20260611T120000
DTSTAMP:20260609T133930
CREATED:20260520T185631Z
LAST-MODIFIED:20260522T082358Z
UID:10499-1781175600-1781179200@thebiocalendar.com
SUMMARY:Using Residual DNA Quantification Data to De-risk mAb Development
DESCRIPTION:IND submission is a critical milestone in mAb development — but analytical methods established at this stage must ultimately support validation\, tech transfer\, and evolving regulatory expectations. Among these\, residual host cell DNA quantitation assays play a central role in monitoring residual impurity levels\, supporting process performance\, and may help reduce downstream risks. \nThis webinar will position residual DNA quantitation not as an isolated assay\, but as a dataset that can be applied across downstream process intermediates to inform decision-making. Using data generated from protein-rich samples\, we will explore how assay sensitivity\, recovery\, and reproducibility perform under realistic manufacturing conditions\, including high IgG matrices. \nThrough practical examples\, attendees will see how residual DNA measurements can be used to compare purification performance across unit operations\, identify potential clearance risks early\, and support development of scalable\, validation-ready processes. The session will also highlight how sample composition and process conditions influence data interpretation\, reinforcing the importance of designing assays that remain robust as workflows evolve. \nLearning objectives: \n~ Evaluate how residual host cell DNA quantitation can be used to assess impurity clearance across downstream mAb process steps\n~ Interpret residual DNA data generated from complex\, protein-rich matrices to support process decision-making\n~ Identify key performance characteristics (e.g.\, sensitivity\, recovery\, reproducibility) required for validation-ready residual DNA assays\n~ Apply strategies for designing residual DNA workflows that remain robust and scalable from development through manufacturing
URL:https://thebiocalendar.com/event/using-residual-dna-quantification-data-to-de-risk-mab-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-11-26-Thermo-Reg-1920x250-0.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260611T160000
DTEND;TZID=America/New_York:20260611T183000
DTSTAMP:20260609T133930
CREATED:20260507T161956Z
LAST-MODIFIED:20260522T082334Z
UID:10397-1781193600-1781202600@thebiocalendar.com
SUMMARY:BVS\, in collaboration with JLL: Biotech Community Innovation Night at 115 Munson\, New Haven
DESCRIPTION:We are very excited to invite you to our BVS\, in collaboration with JLL Biotech Community Innovation Night at 115 Munson! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nWe are inviting all research scientists from the institutes\, biotech and other companies in New Haven and surrounding areas to attend this event. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nBuilding Tours: Building tours of available space are available upon request.\nDelicious Food & Drinks: Enjoy delicious refreshments as you network and explore the vendor exhibits. \nAdmission Details: \n– FREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions\,etc.) from life science companies and research institutes.\n– $200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-innovation-night-at-115-munson-new-haven-4/
CATEGORIES:Expo,Trade Show
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/05/BVS-Biotech-Event-Flyer-06-11-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260614
DTEND;VALUE=DATE:20260619
DTSTAMP:20260609T133930
CREATED:20260316T091256Z
LAST-MODIFIED:20260316T091256Z
UID:10024-1781395200-1781827199@thebiocalendar.com
SUMMARY:DIA 2026 Global Annual Meeting
DESCRIPTION:The DIA Global Annual Meeting is where life sciences professionals from industry\, regulatory agencies\, patients\, and academia come together to drive breakthroughs in healthcare — advancing science\, policy\, and patient outcomes worldwide.
URL:https://thebiocalendar.com/event/dia-2026-global-annual-meeting/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Annual Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260615T110000
DTEND;TZID=America/Los_Angeles:20260615T120000
DTSTAMP:20260609T133930
CREATED:20260519T190644Z
LAST-MODIFIED:20260522T082236Z
UID:10473-1781521200-1781524800@thebiocalendar.com
SUMMARY:Solving Formulation Challenges Across Modalities: Patient-Centric Nanoparticle Approaches for Small and Large Molecules
DESCRIPTION:Explore how advanced nanoparticle engineering is transforming formulation across both small and large molecule modalities. Dr. Chris Worrall highlights how Nanoform’s technologies enable higher drug‑loading oral tablets\, ultra‑high‑concentration biologic formulations for SubQ delivery\, and new possibilities for pulmonary administration. Through real case studies\, you’ll see how nanoforming can reduce pill burden\, unlock patient‑friendly alternatives to IV infusion\, and improve therapeutic performance across modalities. \nKey learning objectives:\n– Overview of Nanoform’s Innovative Small and Large Molecule Nanoforming Technology Platforms to enable patient centric dosage forms\n– Case studies showcasing reduction in pill size and overall pill burden whilst maintaining exposure of supersaturating ASDs\n– A review of alternative dosage forms to IV infusions for large molecule therapeutics
URL:https://thebiocalendar.com/event/solving-formulation-challenges-across-modalities-patient-centric-nanoparticle-approaches-for-small-and-large-molecules/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-15-26-Nanoform-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T110000
DTEND;TZID=America/Los_Angeles:20260616T120000
DTSTAMP:20260609T133930
CREATED:20260519T191458Z
LAST-MODIFIED:20260522T082159Z
UID:10481-1781607600-1781611200@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update June 2026:   Cell Therapy
DESCRIPTION:In this session\, leading cell therapy CDMOs will break down how they support programs across development—from early process work through GMP manufacturing\, scale-up\, and commercial readiness—and where different approaches can reduce downstream risk or introduce it. \nThis is a focused look at who does what\, and where they fit—so you can evaluate partners with greater clarity and move forward with more confidence.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-june-2026-cell-therapy/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-OPCU-1280x720-CELL-THERAPY-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T110000
DTEND;TZID=America/Los_Angeles:20260616T120000
DTSTAMP:20260609T133930
CREATED:20260528T173411Z
LAST-MODIFIED:20260528T173411Z
UID:10549-1781607600-1781611200@thebiocalendar.com
SUMMARY:The Levers And Tradeoffs That Drive Process Productivity
DESCRIPTION:Increasing titers isn’t the only way to maximize process efficiency. Whether you’re optimizing an existing process or developing the next generation of biologics\, we can help you identify the levers that matter most. \nJoin us for an interactive discussion on the process decisions\, tradeoffs\, and operational realities shaping modern biologics manufacturing. Bioprocess Online’s Tyler Menichiello will moderate a conversation with two industry experts bringing firsthand experience in process development and biopharmaceutical manufacturing: \n• David Scherr\, Ph.D.\, Senior Scientist\, Bioprocessing Technologies and Engineering at AstraZeneca\n• Vadim Klyushnichenko\, Ph.D.\, VP\, Biopharmaceutical Development and Quality at Calibr-Skaggs Institute for Innovative Medicines \nScherr and Klyushnichenko will discuss where productivity gains are actually achieved and how teams are finding success by simplifying purification strategies and reducing chromatography steps. They will also explore how less obvious constraints (e.g.\, developability and facility fit) can shape productivity early and how complex molecules like bispecifics are redefining what process efficiency looks like. \nReserve your spot today.
URL:https://thebiocalendar.com/event/the-levers-and-tradeoffs-that-drive-process-productivity/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/26_06-BPOL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T130000
DTEND;TZID=America/Los_Angeles:20260616T140000
DTSTAMP:20260609T133930
CREATED:20260519T191645Z
LAST-MODIFIED:20260522T082135Z
UID:10485-1781614800-1781618400@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update June 2026: Cell Line Development
DESCRIPTION:In this session\, leading CDMO experts will break down the key decisions across host cell selection\, vector design\, and clone screening strategies\, and explain how those choices impact expression\, scalability\, and long-term manufacturability. \nThese presentations will highlight how different CDMO approaches can reduce downstream risk or introduce it\, as programs move from early development into tech transfer and commercial readiness. \nIf you are advancing a monoclonal antibody\, recombinant protein\, or next-generation biologic\, this session will help clarify what to evaluate early—and what to avoid.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-june-2026-cell-line-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-OPCU-1280x720-cell-line-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T100000
DTEND;TZID=America/Los_Angeles:20260617T170000
DTSTAMP:20260609T133930
CREATED:20260501T115107Z
LAST-MODIFIED:20260501T115107Z
UID:10320-1781690400-1781715600@thebiocalendar.com
SUMMARY:Bay Area Life Sciences & Biotech Conference
DESCRIPTION:What You’ll Learn: \n\nGain insights into how renewed leasing activity\, selective capital and improving absorption are reshaping demand\, investment\, and development decisions across the Bay Area life sciences market.\nLearn how owners\, developers\, and operators are rethinking space utilization\, right sizing portfolios\, and repositioning existing assets to meet today’s tenant expectations.\nExamine why South San Francisco and the Peninsula continue to anchor regional growth and how emerging submarkets are positioning themselves to compete for talent and capital.\nGain insights into how architects\, engineers\, and builders are designing flexible\, scalable\, and technology enabled lab environments that can adapt to evolving research and operational needs.\nLearn how universities\, incubators\, and corporate partners are strengthening commercialization pipelines and supporting the next generation of biotech companies.\nGain insight into how AI\, automation\, and data analytics are transforming research workflows\, space management\, and building performance.\nHear the latest strategies for delivering sustainable\, electrified\, and high-performing lab facilities while balancing cost\, compliance\, and long-term value.\n\nHow You’ll Do More Business: After several years of market recalibration\, the Bay Area life sciences sector is entering a new phase defined by selective capital deployment\, shifting demand and location preferences\, and a renewed focus on high-quality\, future-ready assets. Join our full-day conference to hear from and connect with the region’s leading life sciences decision-makers\, capital partners\, developers\, and innovators. You’ll gain the insights\, relationships\, and deal-making opportunities needed to position your business for growth in the next chapter of the Bay Area life sciences market. \nWho You’ll Meet During Networking: Owners\, developers\, investors\, biotech tenants\, brokers\, city and government officials\, business consultants\, architects\, engineers\, lawyers\, accountants\, and bankers. \nWhy You Should Attend This Session: Bisnow events bring together the biggest power players in the industry to help you identify opportunities\, build your network\, and expand your business. With the largest audience of commercial real estate professionals in the world\, no one knows how to help your business more than we do.
URL:https://thebiocalendar.com/event/bay-area-life-sciences-biotech-conference/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
CATEGORIES:Forum,Networking
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T110000
DTEND;TZID=America/Los_Angeles:20260617T120000
DTSTAMP:20260609T133930
CREATED:20260519T124820Z
LAST-MODIFIED:20260522T082112Z
UID:10453-1781694000-1781697600@thebiocalendar.com
SUMMARY:The True Science Behind eCOA\, Shaped By Patient and Site Insights
DESCRIPTION:Clinical trials sit at a unique intersection of science\, patients\, and clinical care\, and for decades\, the “gold standard” has prioritized the rigor of the data\, often at the expense of the patients providing it. This gap between rigid protocol requirements and the realities of patients’ lives is a primary driver of participant hesitancy and high dropout rates. In eCOA\, where patient and site contributions are foundational to data quality\, this tension is especially consequential. Visit frequency\, required tasks\, and device flexibility all shape patient burden\, and these on-the-ground realities are too often absent from protocol design. \nThis webinar brings together patients\, sites\, and eCOA science to dismantle the researcher-subject hierarchy and replace it with a collaborative model. Through a panel discussion\, we’ll translate these perspectives into practical\, real-world insights to guide decisions within your protocol. This session aims to offer a more grounded blueprint for scientifically sound protocol design\, one where patient and site insights are embedded in the DNA of your eCOA strategy. \nKey Themes: \nThe Burden of Participation: Moving from “What data do we need?” to “How will this protocol impact a Tuesday afternoon for a single parent or a working professional?” and what trial design choices around eCOA follow from that shift. \nThe Site Lens: What sites observe firsthand when poor trial design translates to patient burden and operational friction \nTechnology as an Equalizer: How digital tools can reduce participation burden and improve data capture without creating a digital divide that excludes non-tech-savvy participants. \nDefining eCOA Science: What do we even mean by eCOA science? What might different stakeholders be thinking of with this term? And how does it differ from COA science?
URL:https://thebiocalendar.com/event/the-true-science-behind-ecoa-shaped-by-patient-and-site-insights/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-17-26-Medidata-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T110000
DTEND;TZID=America/Los_Angeles:20260617T120000
DTSTAMP:20260609T133930
CREATED:20260519T191814Z
LAST-MODIFIED:20260522T082045Z
UID:10489-1781694000-1781697600@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update June 2026: Microbial Development & Manufacturing
DESCRIPTION:Join us for this digital event designed for pharmaceutical and biopharmaceutical companies seeking reliable CDMO partnerships to accelerate their microbial programs from development through commercial manufacturing. By attending this digital event\, you will learn how these capabilities come together to support efficient development\, smooth scale-up\, and consistent production. \nThe presentations will also provide insight into how experienced partners streamline timelines\, reduce risk\, and address the regulatory and quality considerations critical to successful program execution. \nWhether you are advancing early-stage research or preparing for commercial manufacturing\, you will gain practical guidance to help select a CDMO aligned with your technical\, quality\, and supply chain requirements.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-june-2026-microbial-development-manufacturing/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-OPCU-1280x720-MICROBIAL-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T130000
DTEND;TZID=America/Los_Angeles:20260617T140000
DTSTAMP:20260609T133930
CREATED:20260519T191928Z
LAST-MODIFIED:20260522T082024Z
UID:10493-1781701200-1781704800@thebiocalendar.com
SUMMARY:Outsourced Pharma Capabilities Update June 2026: Antibody Drug Conjugates
DESCRIPTION:In this Capabilities Update\, CDMOs will share how they support ADC programs from early development through clinical and commercial manufacturing. By attending this digital event\, you will gain insight into the technical expertise\, scalability\, and regulatory considerations required to advance ADCs efficiently. \nThe presentations will also highlight key considerations when evaluating CDMO partners\, including experience with complex conjugation processes and the ability to deliver integrated development and manufacturing support. \nWhether you are initiating a new ADC program or refining existing processes\, this session provides a clearer understanding of how to select a partner aligned with your program’s technical and operational needs.
URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-june-2026-antibody-drug-conjugates/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-2026-OPCU-1280x720-ADCs-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260618T110000
DTEND;TZID=America/Los_Angeles:20260618T120000
DTSTAMP:20260609T133930
CREATED:20260515T203642Z
LAST-MODIFIED:20260526T212757Z
UID:10445-1781780400-1781784000@thebiocalendar.com
SUMMARY:When Art Meets Science: Creative Chromatography Solutions for Complex Small Molecules
DESCRIPTION:Difficult to purify small molecules pose a big challenge for drug developers. Working with a CDMO that has specialized expertise in chromatography ensures that no matter the purification challenges or scale\, your program can be taken care of. Learn more…
URL:https://thebiocalendar.com/event/when-art-meets-science-creative-chromatography-solutions-for-complex-small-molecules/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-18-26-MilliporeSigma-eblast-700x200-1.png
END:VEVENT
END:VCALENDAR